Login / Signup

Bone versus soft-tissue setup in proton therapy for patients with oesophageal cancer.

Muhammad ShamshadDitte Sloth MøllerHanna Rahbek MortensenMai Lykkegaard EhmsenMaria Fuglsang JensenLone Hoffmann
Published in: Acta oncologica (Stockholm, Sweden) (2022)
Anatomical changes during the treatment course led to target dose deterioration and a need for plan adaptation when using a bone match.
Keyphrases
  • soft tissue
  • bone mineral density
  • papillary thyroid
  • bone loss
  • bone regeneration
  • combination therapy
  • replacement therapy
  • childhood cancer